G71.035
Limb girdle muscular dystrophy due to anoctamin-5 dysfunction
Clinical Classification Guidelines
Inclusion Terms
- Anoctamin-5-related LGMD R12
- Anoctaminopathy
- Autosomal recessive limb girdle muscular dystrophy type 2L
- Miyoshi myopathy type 3
Medical Intelligence & Overview
Limb Girdle Muscular Dystrophy due to Anoctamin-5 Dysfunction, also known as Anoctaminopathy or LGMD R12, is a rare genetic condition affecting the muscles around the hips and shoulders. This form of muscular dystrophy results from mutations affecting the anoctamin-5 gene, leading to progressive muscle weakness. It is classified under genetic disorders that compromise muscle integrity and function, making daily activities increasingly challenging over time.
Causes & Symptoms
Clinical Causes: Genetic mutations in the ANO5 gene leading to dysfunction of the anoctamin-5 protein Inheritance pattern: autosomal recessive, requiring two copies of the mutated gene Family history of similar muscular dystrophy conditions Potential environmental factors, although primarily a genetic disorder
Key Symptoms: Progressive muscle weakness in the pelvic and shoulder girdle regions Difficulty climbing stairs or rising from a sitting position Muscle cramps and stiffness Delayed motor milestones in children Muscle pain and fatigue after activity Possible development of cardiomyopathy in some cases Muscle wasting and loss of muscle mass over time
Diagnostic & Treatment
Diagnosis Path: Medical history review and physical examination focusing on muscle strength Genetic testing to identify mutations in the ANO5 gene Electromyography (EMG) to evaluate electrical activity in muscles Muscle biopsy to observe muscle tissue changes characteristic of dystrophy Serum creatine kinase (CK) levels, often elevated indicating muscle damage
Treatment Protocols: Physical therapy to preserve muscle strength and prevent contractures Occupational therapy to assist with daily activities Use of mobility aids as needed for walking or standing Monitoring and managing cardiac issues if they occur Pain management approaches, including medications and therapies Regular follow-up with a multidisciplinary team specialized in muscular dystrophies
Clinical Advice & FAQs
Billing Guidance
Is G71.035 a billable ICD-10 code?
Yes, G71.035 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G71.035?
Clinical documentation must specify the nature of Limb girdle muscular dystrophy due to anoctamin-5 dysfunction and any associated comorbidities for accurate reporting.
Cite this Clinical Reference